Spotlight on Research
ASF-funded research at the University of North Carolina makes progress!
The UNC research team has uncovered further possibilities and side effects of using a specific drug to activate the paternal copy of UBE3A. These discoveries are essential to understand before moving into clinical trials. Published in PNAS on November 17, 2014.
Enter the IEP Bank Contest and Win!
Help Us Give Them a Reason to Smile.
The smiles on the faces of individuals with Angelman syndrome (AS) belie a life marked by severe developmental delay, speech difficulties, seizure disorders and more. And yet, they go on smiling. That’s just one reason the Angelman Syndrome Foundation seeks to advance the awareness, understanding and treatment of AS, with the ultimate goal of finding a cure.
Made up of families, caregivers and medical professionals who care about those with Angelman syndrome, the Foundation is a national 501(c)(3) organization dedicated to support individuals with AS, their families and others who care. With your help, we can all give them a reason to smile.